Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Maruho Co. Ltd.

Latest From Maruho Co. Ltd.

Pipeline Watch: Phase III Starts With Mogamulizumab, AR101 And Vilaprisan

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Pipeline Watch: Phase III Progress In Cystic Fibrosis, Spinal Muscular Atrophy And Melanoma

Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.

Pipeline Watch Clinical Trials

Deals Shaping the Medical Industry, October 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in September 2016.

Deals BioPharmaceutical

Maruho Broadens Derma Horizons Through Dual Licensing Deals

Derma specialist Maruho has taken steps to recharge its pipeline through deals with fellow Japanese firms for two novel assets.

Dermatology Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Maruho Co. Ltd.
  • Senior Management
  • Koichi Takagi, Pres.
    Takahide Kitada , Corp. Officer, Strategies & Licensing
    Yasuhiko Kito, Sr. Corp. Officer, Bus. Operations
    Hidehiko Atago, Corp. Officer, Clinical Dev. & R&D Admin.
    Masahiro Akatsuka , Corp. Officer, Research
    Takashi Kitagawa, Corp. Officer, Mktg., Sales Admin. & Dist.
  • Contact Info
  • Maruho Co. Ltd.
    Phone: (81) 63 718 876
    1-5-22 Nakatsu
    Osaka, 531-0071